## **Core Concept**
The question tests understanding of antiglaucoma medications and their mechanisms of action, specifically those that increase uveoscleral outflow. Uveoscleral outflow is an alternative pathway for aqueous humor drainage in the eye, distinct from the conventional trabecular meshwork pathway.

## **Why the Correct Answer is Right**
Prostaglandin analogs, such as **latanoprost**, are known to increase uveoscleral outflow. They work by binding to prostaglandin receptors in the ciliary muscle, which leads to a relaxation of the ciliary muscle and increased permeability of the uveoscleral pathway. This results in enhanced drainage of aqueous humor and a reduction in intraocular pressure (IOP), a key goal in the management of glaucoma.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Beta-blockers (e.g., timolol) decrease aqueous humor production but do not significantly affect uveoscleral outflow.
* **Option B:** Alpha agonists (e.g., brimonidine) work by reducing aqueous humor production and possibly increasing uveotrabecular outflow, but they are not the primary class associated with increased uveoscleral outflow.
* **Option D:** Carbonic anhydrase inhibitors (e.g., acetazolamide) reduce aqueous humor production by inhibiting carbonic anhydrase in the ciliary body, but they do not primarily act by increasing uveoscleral outflow.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that prostaglandin analogs can cause **iris pigmentation changes** and **eyelash growth** as side effects, which are important for patient counseling.

## **Correct Answer:** . Latanoprost.